Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas
Crossref DOI link: https://doi.org/10.1007/s11060-015-1876-0
Published Online: 2015-08-19
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blakeley, Jaishri O.
Grossman, Stuart A.
Mikkelsen, Tom
Rosenfeld, Myrna R.
Peereboom, David
Nabors, L. Burt
Chi, Andrew S.
Emmons, Gary
Ribas, Ignacio Garcia
Supko, Jeffrey G.
Desideri, Serena
Ye, Xiaobu
Text and Data Mining valid from 2015-08-19